- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05722496
Difference Between Interval and Continous Intradialytic Exercise on Functional Capacity in Hemodialysis Patient
Interval Versus Continous Intradialytic Training on Muscla Quality Index and Functional Capacity in Hemodialysis Patients
The goal of this study is to find out the effect of interval versus continous intradialytic training on muscle quality index and functional capacity in Hemodialysis patients. The main question it aims to answer is:
Does interval versus continous intradialytic training have an effect on muscle quality index and functional capacity in hemodialysis patients? Patients will be assigned randomly by computerized block randomization into two groups:Group (A): 30 patients will participate in 8 weeks of aerobic exercise in the form of high intensity interval training (HIIT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).Group (B): 30 patients will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week) . primary and secondary variables will be measured before starting treatment and after completion (after 2 months )
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Individuals with CKD (both predialysis and ESRD) may be at greater risk of sarcopenia given the combined reductions in physical function, skeletal muscle performance and skeletal muscle mass.
Study include sixty male patients on hemodialysis for 1-3 years aged from 45 to 55 years old selected from hemodialysis unit at National Institute of Urology and Nephrology. Before starting treatment , patients will fill consent form and the study aims and procedure will be explained to each patient . study include Sixty male patients on hemodialysis for 1-3 years aged from 45 to 55 years old selected from hemodialysis unit at National Institute of Urology and Nephrology. Patients will be assigned randomly by computerized block randomization into two groups:Group (A): 30 patients will participate in 8 weeks of aerobic exercise in the form of high intensity interval training (HIIT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).Group (B): 30 patients will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week) Karvonen formula will be used to calculate training heart rate THR= RHR+ (HRmax - RHR) 65%-80% AS HRmax = 220-Age patients of HIIT will perform aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer at high intensity 85%-95% of HRpeak with 4 min of active breaks at an intensity of 60%-70% of HRpeak. . Exercise will be done at the first 2 hours of dialysis (to avoid dialysis hypotension episodes).
patients of MICT will perform aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer at moderate intensity 50%-60% of HRpeak . Exercise will be done at the first 2 hours of dialysis (to avoid dialysis hypotension episodes).
primary and secondary variables will be measured before starting treatment and after completion (after 2 months )
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nesreen Gh Elnahhas, professor
- Phone Number: 01002227242
- Email: nesreen.elnahas@pt.cu.edu.eg
Study Contact Backup
- Name: tarek F othman, lecturer
- Phone Number: 260 0222549151
- Email: Tarek.Fakhreldeen@gmail.com
Study Locations
-
-
Dokki
-
Cairo, Dokki, Egypt, 12611
- Faculty of Physical Therapy, Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 45- 55 years.
- Male sex included.
- Patients with grade 5 chronic renal failure on hemodialysis.
- Patients are on hemodialysis for 1-3 years.
- Body mass index (BMI) range from 25-34.9 Kg/m2.
- They will be medically and psychologically stable.
- Receiving their physician-prescribed pharmacotherapy regularly.
- Agree to participate by signing an informed consent form.
Exclusion Criteria:
- Inability to comprehend and follow instructions as in dementia or speech problems such as dysphasia.
- Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
- Acute systemic infection.
- Presence of malignant disease.
- Patients with Diabetes Mellitus.
- Patients with Lupus Nephritis.
- Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
- Severe obesity (BMI > 35).
- Chronic inflammatory orthopedic disorders and rheumatoid arthritis.
- Patients with muscle injuries or neuromuscular disorders (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High Intensity Interval Training Group (Group A)
Each training session consist of three parts of 30 minutes:
|
aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer by different intensities
|
Experimental: Moderate intensity continous training group (Group B)
Each training session consist of three parts of 30 minutes:
|
aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer by different intensities
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
muscle quality index
Time Frame: 2 months
|
The MQI was quantified using a timed sit-to-stand test, body mass, and leg length to calculate a power index that is expressed in watts (W). The MQI was calculated as follows: QI (Watts) = ((Leg length×0.4) ×Bodymass×gravity×10) ∕ Time taken for (sit to stand 5 times) Body mass will be measured using a digital scale. Leg length will be taken using tape measure to measure the distance (in meters) from the greater trochanter of the femur to the lateral malleolus, measured from standing position . BY using a stopwatch, sit-to-stand time will be calculated as the time to stand from a seated position and return to sitting consecutively five times. The use of arms not allowed during the sit-to-stand test. Acceleration of gravity (9.8 m/s2). After measuring leg length, body mass and time for sit to stand, all these data will be written in the previous equation to calculate muscle quality index and expressed in watts (W). |
2 months
|
six minute walk test
Time Frame: 2 months
|
Six minute walk test (6MWT) to assess physical functional capacity (using stopwatch, colored tape to mark starting line and end line of corridor) Using a stopwatch, assess physical functional capability.
The 6MWT will be conducted indoors along a 30 m long, level, straight, enclosed hallway, with the length of the corridor indicated with brightly coloured tape at the beginning and end lines.
Subjects will be advised to walk as far as possible from end to end of the corridor without jogging or running, and to cover as much distance as feasible in the 6 minute time limit .
This test was performed at the beginning of treatment and at the end of treatment program (8 weeks) to assess functional performance difference.
|
2 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: hala m ezz eldeen, professor, department of cardiovascular, respiratory and geriatrics disorders
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 111118
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodialysis Complication
-
National Taiwan University HospitalCompletedHemodialysis Complication | Hemodialysis-Induced SymptomTaiwan
-
Saint-Joseph UniversityTerminated
-
Fresenius Kabi Taiwan Ltd.Chung Shan Medical UniversityCompleted
-
Assiut UniversityNot yet recruitingHemodialysis Complication
-
RenJi HospitalNot yet recruitingHemodialysis Complication
-
China Medical University HospitalMinistry of Science and Technology, TaiwanActive, not recruiting
-
Muş Alparlan UniversityCompletedHemodialysis ComplicationTurkey
-
Rehab WeridaAl-Azhar UniversityCompletedHemodialysis ComplicationEgypt
-
Eurofarma Laboratorios S.A.Completed
-
Universitaire Ziekenhuizen KU LeuvenNIPROCompletedHemodialysis ComplicationBelgium
Clinical Trials on Aerobic pedaling exercise
-
University of HaifaWestern Galilee Hospital-NahariyaUnknownTotal Knee ReplacementIsrael
-
Fondazione Don Carlo Gnocchi OnlusRecruitingIschemic Stroke | Hemorrhagic StrokeItaly
-
Centre Hospitalier Universitaire DijonRecruitingVolunteers Who Can do Moderate Physical ActivityFrance
-
Riphah International UniversityCompleted
-
Sultan Abdulhamid Han Training and Research Hospital...RecruitingPhysical InactivityTurkey
-
University of FloridaAmerican Psychological Foundation; Clinical & Translational Science Institute; American Psychological Association (APA)CompletedBrain ConcussionUnited States
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)TerminatedChildhood ObesityUnited States
-
Radboud University Medical CenterUniversity Hospital, Bonn; University of Dublin, Trinity College; German Sport... and other collaboratorsCompletedMild Cognitive ImpairmentNetherlands, Ireland, Germany
-
National Yang Ming UniversityUnknownKnee OsteoarthritisTaiwan
-
Rush University Medical CenterWithdrawnColorectal Cancer | Chemotherapy | Chemotherapeutic Toxicity | Exercise, AerobicUnited States